These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 35806186

  • 1. New 2-[(4-Amino-6-N-substituted-1,3,5-triazin-2-yl)methylthio]-N-(imidazolidin-2-ylidene)-4-chloro-5-methylbenzenesulfonamide Derivatives, Design, Synthesis and Anticancer Evaluation.
    Tomorowicz Ł, Żołnowska B, Szafrański K, Chojnacki J, Konopiński R, Grzybowska EA, Sławiński J, Kawiak A.
    Int J Mol Sci; 2022 Jun 28; 23(13):. PubMed ID: 35806186
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, Antitumor Evaluation, Molecular Modeling and Quantitative Structure-Activity Relationship (QSAR) of Novel 2-[(4-Amino-6-N-substituted-1,3,5-triazin-2-yl)methylthio]-4-chloro-5-methyl-N-(1H-benzo[d]imidazol-2(3H)-ylidene)Benzenesulfonamides.
    Tomorowicz Ł, Sławiński J, Żołnowska B, Szafrański K, Kawiak A.
    Int J Mol Sci; 2020 Apr 22; 21(8):. PubMed ID: 32331219
    [Abstract] [Full Text] [Related]

  • 3. Synthesis, QSAR studies, and metabolic stability of novel 2-alkylthio-4-chloro-N-(5-oxo-4,5-dihydro-1,2,4-triazin-3-yl)benzenesulfonamide derivatives as potential anticancer and apoptosis-inducing agents.
    Żołnowska B, Sławiński J, Pogorzelska A, Szafrański K, Kawiak A, Stasiłojć G, Belka M, Zielińska J, Bączek T.
    Chem Biol Drug Des; 2017 Sep 22; 90(3):380-396. PubMed ID: 28122174
    [Abstract] [Full Text] [Related]

  • 4. Novel 5-Substituted 2-(Aylmethylthio)-4-chloro-N-(5-aryl-1,2,4-triazin-3-yl)benzenesulfonamides: Synthesis, Molecular Structure, Anticancer Activity, Apoptosis-Inducing Activity and Metabolic Stability.
    Żołnowska B, Sławiński J, Pogorzelska A, Szafrański K, Kawiak A, Stasiłojć G, Belka M, Ulenberg S, Bączek T, Chojnacki J.
    Molecules; 2016 Jun 22; 21(6):. PubMed ID: 27338337
    [Abstract] [Full Text] [Related]

  • 5. Design, Synthesis, and In vitro Anti-cervical Cancer Activity of a Novel MDM2-p53 Inhibitor Based on a Chalcone Scaffold.
    Alimujiang Y, Maimaiti A, Ablise M, Yang Z, Liu Z, Wang Y, Mutalipu Z, Yan T.
    Anticancer Agents Med Chem; 2024 Jun 22; 24(6):423-435. PubMed ID: 38204258
    [Abstract] [Full Text] [Related]

  • 6. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
    Mohamed MF, Hassaneen HM, Elzayat EM, El-Hallouty SM, El-Manawaty M, Saleh FM, Mohamed Y, El-Zohiry D, Fahmy G, Abdelaal N, Hassanin N, Hossam N.
    Anticancer Agents Med Chem; 2019 Jun 22; 19(9):1141-1149. PubMed ID: 30843494
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and Characterization of New Series of 1,3-5-Triazine Hydrazone Derivatives with Promising Antiproliferative Activity.
    H Al Rasheed HHA, M Malebari AM, A Dahlous KA, El-Faham A.
    Molecules; 2020 Jun 11; 25(11):. PubMed ID: 32545272
    [Abstract] [Full Text] [Related]

  • 8. Synthesis, Molecular Structure, Anticancer Activity, and QSAR Study of N-(aryl/heteroaryl)-4-(1H-pyrrol-1-yl)Benzenesulfonamide Derivatives.
    Żołnowska B, Sławiński J, Brzozowski Z, Kawiak A, Belka M, Zielińska J, Bączek T, Chojnacki J.
    Int J Mol Sci; 2018 May 16; 19(5):. PubMed ID: 29772699
    [Abstract] [Full Text] [Related]

  • 9. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors.
    Saleh NM, El-Gaby MSA, El-Adl K, Abd El-Sattar NEA.
    Bioorg Chem; 2020 Nov 16; 104():104350. PubMed ID: 33142416
    [Abstract] [Full Text] [Related]

  • 10. Synthesis, anticancer evaluation and molecular docking studies of new heterocycles linked to sulfonamide moiety as novel human topoisomerase types I and II poisons.
    Halawa AH, Elgammal WE, Hassan SM, Hassan AH, Nassar HS, Ebrahim HY, Mehany ABM, El-Agrody AM.
    Bioorg Chem; 2020 May 16; 98():103725. PubMed ID: 32199303
    [Abstract] [Full Text] [Related]

  • 11. Synthesis, Anticancer Evaluation and Structure-Activity Analysis of Novel (E)- 5-(2-Arylvinyl)-1,3,4-oxadiazol-2-yl)benzenesulfonamides.
    Szafrański K, Sławiński J, Tomorowicz Ł, Kawiak A.
    Int J Mol Sci; 2020 Mar 23; 21(6):. PubMed ID: 32210190
    [Abstract] [Full Text] [Related]

  • 12. Design and synthesis of thienopyrimidine urea derivatives with potential cytotoxic and pro-apoptotic activity against breast cancer cell line MCF-7.
    Abdelhaleem EF, Abdelhameid MK, Kassab AE, Kandeel MM.
    Eur J Med Chem; 2018 Jan 01; 143():1807-1825. PubMed ID: 29133058
    [Abstract] [Full Text] [Related]

  • 13. Design and synthesis of novel isatin-based derivatives targeting cell cycle checkpoint pathways as potential anticancer agents.
    Yousef MA, Ali AM, El-Sayed WM, Qayed WS, Farag HHA, Aboul-Fadl T.
    Bioorg Chem; 2020 Dec 01; 105():104366. PubMed ID: 33212312
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synthesis and bioassay of 3-Aryl -1-(pyridin-4-yl)benzo[4,5]imidazo[1,2-d][1,2,4]- triazin-4(3H)-ones as anti-cancer agents.
    Thaher BA, Al-Masri I, Wahedy K, Morjan R, Aliwaini S, Al Atter IM, Elmabhouh AA, Ibwaini AKA, Alkhaldi SL, Qeshta B, Jacob C, Deigner HP.
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Aug 01; 396(8):1797-1810. PubMed ID: 36856800
    [Abstract] [Full Text] [Related]

  • 16. Novel 2-alkythio-4-chloro-N-[imino(heteroaryl)methyl]benzenesulfonamide Derivatives: Synthesis, Molecular Structure, Anticancer Activity and Metabolic Stability.
    Żołnowska B, Sławiński J, Belka M, Bączek T, Chojnacki J, Kawiak A.
    Int J Mol Sci; 2023 Jun 05; 24(11):. PubMed ID: 37298719
    [Abstract] [Full Text] [Related]

  • 17. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators.
    Al-Oudat BA, Alqudah MA, Audat SA, Al-Balas QA, El-Elimat T, Hassan MA, Frhat IN, Azaizeh MM.
    Drug Des Devel Ther; 2019 Jun 05; 13():423-433. PubMed ID: 30774307
    [Abstract] [Full Text] [Related]

  • 18. Antiproliferative effect, cell cycle arrest and apoptosis generation of novel synthesized anticancer heterocyclic derivatives based 4H-benzo[h]chromene.
    Alblewi FF, Okasha RM, Hritani ZM, Mohamed HM, El-Nassag MAA, Halawa AH, Mora A, Fouda AM, Assiri MA, Al-Dies AM, Afifi TH, El-Agrody AM.
    Bioorg Chem; 2019 Jun 05; 87():560-571. PubMed ID: 30928878
    [Abstract] [Full Text] [Related]

  • 19. Structure-Based Design: Synthesis, X-ray Crystallography, and Biological Evaluation of N-Substituted-4-Hydroxy-2-Quinolone-3-Carboxamides as Potential Cytotoxic Agents.
    Sabbah DA, Hishmah B, Sweidan K, Bardaweel S, AlDamen M, Zhong HA, Abu Khalaf R, Hasan Ibrahim A, Al-Qirim T, Abu Sheikha G, Mubarak MS.
    Anticancer Agents Med Chem; 2018 Jun 05; 18(2):263-276. PubMed ID: 28901259
    [Abstract] [Full Text] [Related]

  • 20. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
    El-Helby AA, Sakr H, Ayyad RRA, El-Adl K, Ali MM, Khedr F.
    Anticancer Agents Med Chem; 2018 Jun 05; 18(8):1184-1196. PubMed ID: 29651967
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.